US 10653749
Targeting GIV-GEF-GI signaling for treating diverse diseases
granted A61KA61K38/00A61K38/1741
Quick answer
US patent 10653749 (Targeting GIV-GEF-GI signaling for treating diverse diseases) held by The Regents of the University of California expires Mon May 14 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue May 19 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 14 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 29
- CPC classes
- A61K, A61K38/00, A61K38/1741, A61K38/179, A61P